DT
PVCT

Diversified Trust’s PROVECTUS BIOPHARMACEUTICALS, INC. (DE) PVCT Stock Holding History

Diversified Trust’s Portfolio PVCT Stock Details PVCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-50,000
Closed -$2K – 872
2022
Q3 		$2K Hold
50,000
– – ﹤0.01% 766
2022
Q2 		$3K Buy
+50,000
New +$3K ﹤0.01% 742

Other funds holding PVCT

HFBOT
Home Federal Bank of Tennessee Knoxville, Tennessee $463M AUM 24.62% 1-Year Est. Return
LDB
Lee, Danner & Bass Nashville, Tennessee $1.73B AUM 36.69% 1-Year Est. Return
AW
Atlas Wealth Cincinnati, Ohio $334M AUM 11.57% 1-Year Est. Return
LIA
LBMC Investment Advisors Brentwood, Tennessee $1.64B AUM 15.26% 1-Year Est. Return
ACM
Academy Capital Management Waco, Texas $699M AUM 12.08% 1-Year Est. Return
AA
Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return

Diversified Trust's PVCT Position: Q4 2022 in Review

Diversified Trust sold out of PROVECTUS BIOPHARMACEUTICALS, INC. (DE) (PVCT) in Q4 2022, closing a stake of 50,000 shares — an estimated $2K sold.

Diversified Trust first reported a position in PVCT in Q2 2022 and held it in 2 quarters. The position peaked at $3K in Q2 2022. 7 funds tracked by Wall St. Rank hold PVCT as of Q4 2022.

  • Diversified Trust reported no remaining PROVECTUS BIOPHARMACEUTICALS, INC. (DE) position as of Q4 2022 after selling out during the quarter.
  • Diversified Trust sold 50,000 PROVECTUS BIOPHARMACEUTICALS, INC. (DE) shares in Q4 2022, an estimated $2K.
  • Diversified Trust first reported a position in PROVECTUS BIOPHARMACEUTICALS, INC. (DE) in Q2 2022 and held it in 2 quarters.
  • Diversified Trust's PROVECTUS BIOPHARMACEUTICALS, INC. (DE) position peaked at $3K in Q2 2022.
  • 7 funds tracked by Wall St. Rank held PROVECTUS BIOPHARMACEUTICALS, INC. (DE) as of Q4 2022.

Based on Diversified Trust's 13F filing for Q4 2022, filed 17 Jan 2023.